PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 2, 2026Neurology International0 citationsOpen Access

A Comparative Study of Clinical and Demographic Profiles of Multiple Sclerosis Patients in Two Regional Centers in Denmark and Romania

View Full Paper
OVOana VrînceanuRBRodica BălașaSMSmaranda Maier

Key Points

  • The study aims to compare the clinical and demographic profiles of multiple sclerosis patients across two regional centers.
  • Conducted a cross-sectional, observational cohort study.
  • Data collected from Danish Multiple Sclerosis Center and Regional MS Center in Romania.
  • Compared demographic and clinical characteristics including sex distribution, age, EDSS scores, and ongoing DMT.
  • Females constituted 69.2% in Denmark and 65.7% in Romania.
  • Pyramidal symptoms were more common in Romanian patients (32.7%), while sensory symptoms were dominant in Denmark (33%).
  • Progressive MS forms were observed in 22.6% of Romanian patients versus 9.9% in Denmark.
  • 58.3% of Danish patients were on high-efficacy DMTs compared to 29.4% in Romania.

Abstract

Background: Environmental factors are known to influence the clinical presentation of patients with multiple sclerosis. This study aims to compare the demographic and clinical characteristics of multiple sclerosis patients treated at two diverse geographical settings. Methods: A cross-sectional, observational cohort study was conducted in two MS centers: the Danish Multiple Sclerosis Center (DMSC) in Copenhagen, Denmark and the Regional MS Center in Târgu Mureș, Romania. We compared patients’ demographic and clinical characteristics between MS centers, including sex distribution, current age, MS onset age, latest EDSS scores, symptomatology at disease onset, MS phenotype and type of ongoing DMT. Results: In both cohorts, sex distribution was similar, with females constituting 69.2% in DMSC, and 65.7% in Târgu Mureș. Pyramidal symptoms at MS onset were predominant among Targu Mures patients (32.7%), while sensory symptoms were more frequent among DMSC patients (33%). Progressive forms of MS were more prevalent in Târgu Mureș (22.6%) compared to DMSC (9.9%). High-efficacy DMTs were on use by 58.3% patients in DMSC and only by 29.4% patients in Târgu Mureș, who were mostly on low-efficacy DMTs (54.4% vs. 12.4% in DMSC). Conclusions: The study highlights both shared and distinct characteristics of MS patients treated in these two centers. These findings underscore the importance of regional considerations in the management and treatment of MS.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Vrînceanu et al. (2026) studied this question.

synapsesocial.com/papers/6980fd60c1c9540dea80f265https://doi.org/10.3390/neurolint18020025
Ask AI
Helpful
Bookmark
Share
View Full Paper